The 10 new flu-related deaths in children bring the season's total to 226, the most since 2009-10.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Older people were more likely to report symptoms and have abnormal chest imaging and lung function.
The oral antiviral drug Paxlovid is safe and effective for treating COVID-19 and carries no additional risk of viral rebound beyond other treatments, according to a meta-analysis published late last week in the Journal of Infection.
In the past, increasing cases in Europe have come ahead of similar rises in other regions.
Inundated US hospitals held patients in places like hallways for a median of 6.6 hours.
Uganda's health ministry on Twitter today reported four more lab-confirmed Ebola Sudan cases, as well as one more death in a patient with a confirmed infection. The developments push the country's overall total to 54 cases, 35 of them confirmed and 19 listed as probable. The latest death brings Uganda's fatality count to 25, 7 in confirmed patients and 18 in people who had probable infections.
The SARS-CoV-2 Omicron variant is much more transmissible among household members than Delta, with an estimated secondary attack rate (SAR) from thrice-vaccinated index patients of 46%, compared with 11% for Delta, finds a study published today in Nature Communications.
The SAR is the percentage of contacts who become infected by an index (initial) patient.
The shots offered 74% protection against hospitalization or death and 90% against death alone.
The change was temporary and "within the normal range of variation."
Cases are down 11% worldwide and deaths declined 18%, with the greatest decrease in cases in Africa.
High-flow oxygen didn't significantly lower death rates beyond those of standard oxygen therapy in COVID-19 patients with respiratory failure, according to a multicenter randomized clinical trial published yesterday in JAMA.
